The COVID-19 Vaccine Dilemma
6 Admin. L. Rev. Accord (Nov. 2020, Forthcoming)
43 Pages Posted: 30 Jun 2020 Last revised: 15 Oct 2020
Date Written: June 29, 2020
COVID-19 has led to large numbers of deaths, harms, and financial costs. Without an effective vaccine, those will continue. The pressure to find a vaccine is high; and that pressure creates a risk that the safeguards in place to assure that vaccines are safe and effective will be ignored. The U.S. has an extensive apparatus to oversee vaccine safety before and after licensing, including multiple federal committees and several monitoring systems, and that apparatus gave us, in 2020, an extraordinarily safe vaccine supply. This article explains the different pressures that push for and against using the same apparatus for COVID-19 vaccines, including the extensive harms from the disease on one side and the need for a vaccine that is, in fact, safe and effective from the other. It examines the options for speeding up the process without sacrificing too much oversight. It examines which “shortcuts” are reasonable, which may be challenging, and which are bad ideas. Finally, it addresses three messaging challenges - overselling, undersharing, and responding to misinformation - and suggests how to handle them.
Keywords: Vaccines, COVID-19, Public Health, FDA, CDC
JEL Classification: H51, I18, I28, K20
Suggested Citation: Suggested Citation